申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2012088314A1
公开(公告)日:2012-06-28
Compounds and compositions comprising compounds including formula (I) that activate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that activate PKM2 in the treatment of cancer.
本文描述了包含激活丙酮酸激酶M2(PKM2)的化合物和组合物,其中化合物包括式(I)。本文还描述了利用激活PKM2的化合物治疗癌症的方法。